CABA

Conviction 42HealthcareScan · Mon, Aug 10, 2026

Bullish engulfing

CABA$2.80+0.36%

ResistanceSupportVol 14

Vol MA14 3.3M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Cabaletta Bio, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.cabalettabio.com ↗

Price2.80

Change+0.36%

Gap-0.72%

Rel volume3.68×

Avg volume3.23M

Avg $ vol8.85M

SMA 202.73

SMA 502.97

SMA 2002.86

Price vs 50-5.80%

Price vs 200-2.03%

MA stackmixed

50/200 cross—

Supertrenddown · 3.12

RSI (14)49

MACD hist0.03

MACD crossbull · 7d

Stoch %K / %D89 / 75

ADX (14)18

+DI / −DI12 / 16

RSI divergenceBullish

MACD divergenceBullish

ATR %+5.65%

ADR %4.91%

52w high4.15

52w low1.33

From 52w high-32.53%

Above 52w low+110.53%

New 52w highNo

SqueezeOn · 5d

Bollinger width7.81%

%B0.81

Donchian pos75.00%

Donchian high2.87

Donchian low2.59

AVWAP (52w high)3.14

vs AVWAP high-10.89%

AVWAP (52w low)2.88

vs AVWAP low-2.82%

OBV trendFlat

Chaikin MF (20)0.10

Today vs 20d3.68×

Avg vol (14d)3.3M

Avg vol (20d)3.23M

Avg $ vol (20d)8.85M

Market cap—

RS 3m (vs SPY)-35.95%

RS 6m (vs SPY)+5.63%

RS line new highNo

Trend template3/8

Technical rank48.7

1 week+4.09%

1 month-5.88%

3 months-27.84%

6 months+11.55%

1 year+93.10%

YTD+26.70%

P/E-2.71

P/B4.40

P/S—

P/FCF-3.44

EPS-2.10

Div yield—

ROE-162.49%

ROA-113.30%

Debt/Eq—

Current2.95

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-44.87%

Price target15.75

Target upside464.52%

Analyst ratingBuy

Institutional72.30%

Ent. value338.29M

Revenue—

Net income-43.52M

Gross profit—

Free cash flow-132.31M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out163.05M

Employees158

ListedFri, Oct 25, 2019

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction42 / 100

Pattern quality—

Tech rank48.7 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish engulfing

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CABA

All disclosures →

No recent disclosed trades by Congress in CABA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CABA · 5 buys

Insider	Side	Shares	Value	Traded	Filed
Brun Scott C. Director · Stock Option (Right to Buy) · 2026-06-09	Grant	22K	$0	2026-06-09	2026-06-10
HENRIQUES RICHARD C JR Director · Stock Option (Right to Buy) · 2026-06-09	Grant	22K	$0	2026-06-09	2026-06-10
Simon Mark Director · Stock Option (Right to Buy) · 2026-06-09	Grant	22K	$0	2026-06-09	2026-06-10
Bollard Catherine Director · Stock Option (Right to Buy) · 2026-06-09	Grant	22K	$0	2026-06-09	2026-06-10
Tomasello Shawn Director · Stock Option (Right to Buy) · 2026-06-09	Grant	22K	$0	2026-06-09	2026-06-10

SEC filings

EDGAR filings in CABA · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.